Co-Diagnostics

Co-Diagnostics Supply Chain

Supply Chain of Co-Diagnostics (CODX) as of Nov 20, 2026.

Supply Chain

-

Last updated:

Supply chains in stock corporations are essential components of business infrastructure and play a crucial role in value creation and competitiveness. These supply chains encompass all steps from raw material procurement and production to the delivery of finished products to the end customer.

Co-Diagnostics Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
4 companies
#NameTrend
1
American Bio Medica
Customer·Health Care Equipment & Supplies·US
-0.52
0.53
0.68
0.82
0.53
0.84
2
PolarityTE
Customer·Biotechnology·US
0.59
0.74
0.62
0.76
0.63
0.79
#NameTrend
1
Krebs Biochemicals & Inds
Supplier·Customer·IN
0.06
0.79
-0.18
0.51
-0.09
-0.67
2
Walgreens Boots Alliance
Customer·Food & Staples Retailing·US
-0.16
0.18
0.61
0.64
0.42
-0.43

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Co-Diagnostics Stock analysis

What does Co-Diagnostics do? Co-Diagnostics, Inc. develops and sells diagnostic tests using proprietary reagents and a test design system for diseases and pathogens including tuberculosis, drug-resistant tuberculosis, hepatitis B and C, malaria, dengue, HIV, and Zika virus. The company also markets self-contained lab systems (MDx devices) from other manufacturers. Its products are sold to laboratories and healthcare providers for molecular testing of organisms and genetic diseases, automating complex procedures in test development and administration. The firm generates revenue through the sale of diagnostic reagents, validated tests, and MDx devices. The company's diagnostic technology focuses on nucleic acid detection and analysis, enabling molecular testing for various pathogens and genetic conditions. Its proprietary system allows for the design and validation of tests in-house, which are then marketed to healthcare institutions. Revenue streams include reagent sales, test kits, and equipment from partner manufacturers. Co-Diagnostics, Inc. targets laboratories and healthcare providers as key customers for its diagnostic solutions. The firm's products are designed to streamline molecular testing processes, reducing the complexity of traditional methods. This approach supports the company's revenue model based on direct sales of its proprietary tests and complementary equipment. Co-Diagnostics is one of the most popular companies on Eulerpool.

All Key Metrics — Co-Diagnostics